Literature DB >> 1588468

Host defense system interactions with Candida.

R A Greenfield1.   

Abstract

Mesh：

Year:  1992        PMID： 1588468

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN： 0268-1218


× No keyword cloud information.
  17 in total

1.  Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice.

Authors:  R D Wagner; C Pierson; T Warner; M Dohnalek; J Farmer; L Roberts; M Hilty; E Balish
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 2.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

3.  Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus.

Authors:  S Elahi; G Pang; R Ashman; R Clancy
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

4.  Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells.

Authors:  S L Newman; A Holly
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

5.  Intravenous injection of Candida-derived mannan results in elevated tumor necrosis factor alpha levels in serum.

Authors:  R E Garner; J A Hudson
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

6.  CD86 (B7-2), but not CD80 (B7-1), expression in the epidermis of transgenic mice enhances the immunogenicity of primary cutaneous Candida albicans infections.

Authors:  A A Gaspari; R Burns; A Nasir; D Ramirez; R K Barth; C G Haidaris
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans.

Authors:  G Arancia; A Molinari; P Crateri; A Stringaro; C Ramoni; M L Dupuis; M J Gomez; A Torosantucci; A Cassone
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Molecular typing of Candida albicans in oral candidiasis: karyotype epidemiology with human immunodeficiency virus-seropositive patients in comparison with that with healthy carriers.

Authors:  A Lupetti; G Guzzi; A Paladini; K Swart; M Campa; S Senesi
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

9.  Candida albicans cell walls contain the fluorescent cross-linking amino acid dityrosine.

Authors:  E H Smail; P Briza; A Panagos; L Berenfeld
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Protection against murine disseminated candidiasis mediated by a Candida albicans-specific T-cell line.

Authors:  T G Sieck; M A Moors; H R Buckley; K J Blank
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.